Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $4.8 million.

  • Amphastar Pharmaceuticals' Non-cash Items fell 401.13% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 401.13%. This contributed to the annual value of $4.9 million for FY2024, which is 1467.48% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Non-cash Items of $4.8 million as of Q3 2025, which was down 401.13% from $20.0 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Non-cash Items ranged from a high of $208.0 million in Q3 2023 and a low of $500000.0 during Q2 2021
  • In the last 5 years, Amphastar Pharmaceuticals' Non-cash Items had a median value of $5.9 million in 2023 and averaged $49.1 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Non-cash Items plummeted by 9925.35% in 2021 and then skyrocketed by 2763300.0% in 2022.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Non-cash Items stood at $500000.0 in 2021, then soared by 1010.14% to $5.6 million in 2022, then increased by 2.44% to $5.7 million in 2023, then fell by 14.67% to $4.9 million in 2024, then dropped by 1.7% to $4.8 million in 2025.
  • Its Non-cash Items was $4.8 million in Q3 2025, compared to $20.0 million in Q2 2025 and $46.4 million in Q1 2025.